Surveillance vs. endoscopic treatment for Barrett's esophagus with low-grade dysplasia
Part of Cancer, Digestive system clinical trials.
This study compares two approaches for people with Barrett's esophagus and low-grade dysplasia: regular surveillance (monitoring with endoscopies) versus endoscopic treatment to remove the abnormal cells. It aims to see which approach is better at preventing progression to more serious conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years old or older
- diagnosed with Barrett's esophagus and low-grade dysplasia (or uncertain dysplasia) in the last 12 months
- be able to take acid-reducing medication (like proton pump inhibitors)
- be able to pause blood thinners around the study procedures
- not have had prior endoscopic treatment for Barrett's esophagus
- not have had high-grade dysplasia or esophageal cancer in the past
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether it's safe to stop regular surveillance endoscopies for people with low-risk Barrett's esophagus. If you have a short Barrett's segment without any dysplasia, you may be able to avoid future procedures.
This trial tests a device that collects cells from the esophagus using a swallowed capsule, which may detect Barrett's esophagus without a standard endoscopy. It is for people who are already scheduled for an endoscopy.
This study compares two endoscopic treatments to remove abnormal cells in Barrett’s esophagus and lower the chance of it worsening. If you qualify, you may be assigned to one of the two procedures and followed to see how well they work and how safe they are.
This study compares two ways doctors remove abnormal tissue in the esophagus during endoscopy: EMR versus ESD. It may help improve how safely and completely these lesions are removed, while also comparing outcomes between the two methods.
This study tests less invasive ways to detect high-grade dysplasia (very abnormal cells) and esophageal cancer in people with Barrett's esophagus, a condition that can increase cancer risk. It looks for these changes using cell samples taken during a routine endoscopy, which may be quicker and more comfortable than standard biopsies.
This study compares two ways of taking tissue samples during endoscopy to check how Barrett’s esophagus is changing. The goal is to improve surveillance, especially for finding early precancer or early cancer changes.
Hear when a new Barretts Esophagus With Dysplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.